Who
Edward J. Brennan
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Medicus Pharma.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Jul 2025
- Last trade
- 4 Sep 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 8 Sep 2026 | MDCX Medicus PharmaBiotechnology | SEC FORM 4 Code A | $100K588,235 at $0.1705 | filing |
| 4 Sep 2026filed 8 Sep 2026 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 4 Sep 2026filed 8 Sep 2026 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 4 Sep 2026filed 8 Sep 2026 | MDCX Medicus PharmaBiotechnology | SEC FORM 4 Code A | $100K588,235 at $0.17 | filing |
| 3 Jun 2026filed 4 Jun 2026 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 30 Mar 2026filed 1 Apr 2026 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 30 Mar 2026filed 1 Apr 2026 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 16 Dec 2025filed 18 Dec 2025 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Jul 2025filed 24 Jul 2025 | MDCX Medicus Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.